NOX to report at ESMO, page-4

  1. 1,639 Posts.
    lightbulb Created with Sketch.  10
    Yes Stay, has been a strong performer. Thanks for sharing that.

    Better news is it is going to be very busy year on the trial front, going to find out a lot about Idronoxil-C's potential in various trial settings.

    Great stock to be involved in and buyers chipping away at it this week. Potential is huge.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.